ClinicalTrials.gg
Sign In

Vaccine-Preventable Diseases clinical trials

The registry lists 53 studies for Vaccine-Preventable Diseases across more than 10 countries. 12 are recruiting or about to start. 26 of them are mainly about Vaccine-Preventable Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Vaccine-Preventable Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
29
Recruiting
8
Status unknown
6
Active, not recruiting
4
Not yet recruiting
4
Terminated
1

Phase

Phase 4
9
Phase 2
6
Phase 3
6
Phase 1
5
Early Phase 1
1

Where

United States
16
Thailand
4
Australia
3
Canada
3
Netherlands
2
Denmark
2

Who runs them

Chiang Mai University (4) · Dynavax Technologies Corporation (3) · Bandim Health Project (2) · Zhejiang Provincial Center for Disease Control and Prevention (2) · Children's Hospital Medical Center, Cincinnati (2) · Beijing Luzhu Biotechnology Co., Ltd. (2) · Michigan State University (2) · Corewell Health East (1)

What is being tested here

Drugs under test in Vaccine-Preventable Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
BCG Vaccine101
Measles Vaccine101
NVX-CoV2373 adjuvated lipid nanoparticle002
Shingrix001
OVX836001
Ty21a Typhoid Vaccine001
Ferric carboxymaltose001

Coming up

2phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 8 Vaccine-Preventable Diseases studies recruiting now, 2 (25%) set no upper age limit and 6 (75%) stop at 75 or younger. 5 (63%) take children under 18. 1 (13%) are for women only and 1 (13%) for men only; 8 (100%) take healthy volunteers.

Recruiting studies that take each age, of 8
AgeWomenMen
102 (25%)2 (25%)
183 (38%)3 (38%)
305 (63%)4 (50%)
404 (50%)4 (50%)
503 (38%)3 (38%)
653 (38%)3 (38%)
753 (38%)3 (38%)
852 (25%)2 (25%)

Across all 53 studies, recruiting or not: 62% stop at 75 or younger and 55% at 65; 42% take children; 6% are for women only and 2% for men only; 81% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vaccine-Preventable Diseases studies take

Of 17 interventional studies with no phase under Vaccine-Preventable Diseases, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase8 mo3–20 · 17 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 53. Browse all 53 → or search them.